Group 1 - The core viewpoint of the news highlights the advancements in the Tianju Energy's ultra-high modulus digital manufacturing project, which significantly enhances production efficiency and energy utilization [1] - The project has improved production efficiency by over three times compared to traditional production lines and has achieved an energy utilization rate exceeding 90% with a 20% reduction in energy consumption intensity [1] - The initiative represents a transition from traditional building materials to high-end equipment materials, thereby enhancing the company's core competitiveness [1] Group 2 - The collaboration between Yishui County and various universities and research institutions aims to strengthen innovation through talent acquisition and technology development [2] - Yishui County is focused on integrating industry with technology and talent, promoting a collaborative environment for core technology breakthroughs and advanced research results [2] - Future efforts will concentrate on nurturing enterprises, enhancing project construction, and building a modern industrial system centered on new materials and new energy [2]

在雄安新区，类似的平台载体有很多。雄安新区着力打造国家级前沿创新平台、产业孵化创新平台、成 果转化创新平台"三类创新平台"，打造启动区及第五组团联动容东片区、自由贸易试验区、国家高新区 3个科技创新集聚区，已建成科创中心、中试基地、软创街区等10余个创新平台载体，建成智能网联、 智慧能源、机器人创新中心等20余栋主题楼宇。构建"专业产业园+主题楼宇+孵化器+众创空间"发展模 式，形成从原始创新到大规模商用各环节的创新体系，为高端高新产业发展提供创新土壤。 高端高新产业发展离不开技术创新。雄安新区坚持创新链、产业链、人才链、资金链、供应链、价值 链"六链融合"，优先发展新一代信息技术、现代生命科学和生物技术、新材料产业。 金属3D打印机轰鸣作响，叉车有序运送物料，工人忙着调试设备、检查生产线……在北京煜鼎增材制 造研究院股份有限公司的研发生产车间，各项生产井然有序。2024年9月，公司总部暨国家级创新研发 平台"大型金属构件增材制造国家工程实验室"整体迁址至雄安新区。"我们正抓紧推进国家重大专项科 研生产任务，截至目前已有10多个模块产品开始进行后处理工作，各项工作进展顺利。"公司总经理王 富伟说。 雄安新区， ...

（文章来源：每日经济新闻） 凤栖谷科技创新产业园充分发挥国家级新区资源禀赋优势，聚焦低空经济、集成电路、新能源、新材料 等战略性新兴产业和未来产业，重点打造中试熟化的试验场、成果转化的孵化园和楼宇经济的承载地， 全力推动科技成果从实验室走向生产线；并通过创新产业链招商、以商招商、定制招商等新模式，引导 企业总部、研发、中试及轻型制造等环节向工业楼宇集中，构建"研发—中试—产业化"一体化的创新型 产业生态。针对"工业上楼"这一新型产业模式，凤栖谷科技创新产业园立足于科技成果转化的先决条 件，从"环保安全、设备载重"等工业上楼五要素出发，试点"一体化环评"，筛选适配企业。成都天投集 团根据企业需求定制服务，充分满足企业生产发展需要，在一栋楼内实现科研、小试、中试、产业化全 过程。 作为凤栖谷科技创新产业园的首批入驻企业之一，成都天齐增材智造有限公司及全资子公司成都登特牙 科技术开发有限公司目前已完成整体搬迁，正式投入运营。成都天齐增材智造有限公司市场部负责人高 邦奎表示："近年来，天齐增材、登特义齿积极融入天府新区产业布局，发挥增材制造'材料-打印-应 用'全产业链优势，推动精准医疗、工业应用等新兴产业发展。我们 ...

Group 1: Aerospace Industry - The "Spectrum" rocket developed by German Isar Aerospace failed shortly after launch from Norway, highlighting the high-risk nature of aerospace engineering and the gap between capital enthusiasm and technological innovation [1] - Isar Aerospace has raised over €400 million from investors, including Porsche Holding, indicating significant financial backing for its ventures [1] Group 2: Aviation Industry - Eastern Airlines' domestically produced C919 aircraft successfully completed its first commercial operation in Northeast China, landing in Shenyang, marking the 10th city to have C919 service [2] - This event signifies the beginning of commercial operations for domestically produced large aircraft in the Northeast region of China [2] Group 3: Technology and Innovation - The first embodied intelligence innovation industrial park has been established in Haidian, Beijing, with a current occupancy rate of 30%, attracting several prominent companies in the field [3] - The development of embodied intelligence is seen as a new competitive arena in global technology, requiring not only algorithmic breakthroughs but also systemic innovations in hardware and interaction [3]

Core Insights - The Suzhou Health Medical Intelligent Innovation Industry Fund was officially launched with a total scale of 1 billion yuan and an initial scale of 300 million yuan, focusing on the integration of "artificial intelligence + healthcare" in Suzhou [1][2] Group 1: Fund and Investment Focus - The fund is initiated by Guoxin Zhongshu and the Suzhou Health Commission, aiming to support the incubation of innovative projects in AI healthcare, targeting areas such as AI diagnosis, drug target discovery, AI health management, AI hospital operations, and medical robotics [2] - The fund will select high-value and high-potential entrepreneurial teams or companies based on the demand in the healthcare industry [2] Group 2: Laboratory and Data Resources - The Suzhou Health Medical Intelligent Innovation Laboratory and other related labs have been launched, with an initial investment of 160 million yuan, creating a trusted data space for the healthcare industry [2] - The health data resource pool of the Suzhou Health Medical Intelligent Innovation Laboratory currently contains over 70 billion data entries, covering clinical diagnosis, public health, and biological samples [2] Group 3: Collaborative Innovation - A series of strategic cooperation agreements were signed among various institutions and companies to build a collaborative innovation ecosystem in the healthcare sector [3] - The collaboration aims to accelerate the transformation of research outcomes and product promotion within the healthcare ecosystem [3] Group 4: Future Development Plans - The implementation plan for accelerating the integration of "artificial intelligence + healthcare" includes two major development goals by the end of 2026: launching at least 15 large model application projects and cultivating at least 15 vertical large models [4] - Three key tasks include building AI capability centers, accelerating the application of various scenarios, and supporting the development of health industries [4] - A comprehensive execution plan will be established to promote collaboration across the healthcare industry over the next three years [4]

证券代码：300832 证券简称：新产业 公告编号：2025-015 深圳市新产业生物医学工程股份有限公司 | 序 号 | 产品名称 | 有效期 | 证书编号 | 临床用途 | | --- | --- | --- | --- | --- | | | 学发光法） | | | | | 10 | Total T4 (CLIA) | 有 效 期 至 | No. V12 105113 | | | | 总甲状腺素测定试剂盒（磁微粒化学发光法） | 2025-12-14 | 0005 Rev. 02 | | | 11 | Free T4 (CLIA) | 有 效 期 至 | No. V12 105113 | | | | 游离甲状腺素测定试剂盒（磁微粒化学发光法） | 2025-12-14 | 0005 Rev. 02 | | | 12 | Rev T3 (CLIA) | 有 效 期 至 | No. V12 105113 | | | | 反三碘甲状腺原氨酸测定试剂盒（磁微粒化学 | 2025-12-14 | 0005 Rev. 02 | | | | 发光法） | | | | | | Toxo IgG (CLIA) | 有 效 ...

Group 1 - The company Tianjin Zhengxin Yujian New City Renewal Industry Operation Co., Ltd. has been established with a registered capital of 1 billion RMB [1][2] - The legal representative of the company is Wang Mianzong, and it is wholly owned by Tianjin Zhengxin Asset Operation Management Co., Ltd. [1][2] - The company's business scope includes park management services, non-residential real estate leasing, house demolition services, information consulting services, planning and design management, marketing planning, property management, engineering management services, and various other services [1] Group 2 - The company is classified under the real estate industry, specifically in real estate development and operation [2] - The registered address of the company is located at Meijiang Center Building, 6th Floor, Youyi South Road, Hexi District, Tianjin [2] - The company is a limited liability company with a business term set until March 25, 2025, with no fixed expiration date [2]

Core Viewpoint - A series of collaborative innovation platforms focusing on cutting-edge technologies have recently emerged, showcasing advancements in the field of new energy smart connected vehicles, particularly in solid-state batteries and BeiDou navigation technologies [1] Group 1: Solid-State Battery Advantages - Solid-state batteries are considered the "ultimate solution" for next-generation power batteries due to their higher safety, greater energy density, longer lifespan, and faster charging speed compared to the currently prevalent lithium-ion batteries [1] - Many countries globally are accelerating their investments and developments in solid-state battery technology [1] Group 2: Industry Developments and Future Outlook - Collaborative innovation platforms involving academia, industry, and research have made breakthroughs in key material fields [1] - According to Ouyang Minggao, an academician at the Chinese Academy of Sciences, vehicle testing for solid-state batteries is expected to begin by the end of this year or next year, with large-scale production anticipated by 2027, although it is still in the demonstration verification phase [1] - Mass production of solid-state battery products is expected to be realized before 2030 [1]

本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 近日，深圳市新产业生物医学工程股份有限公司（以下简称"公司"）收到 了广东省药品监督管理局颁发的 1 项《医疗器械注册证》。具体情况如下： | 胰岛素样生长 因子Ⅰ测定试 | Ⅱ类 | 粤械注准 | 2025 | 年 | 03 月 | 17 | 日至 | 本试剂盒用于定量测定人 血清或血浆中胰岛素样生 长因子Ⅰ（IGF-Ⅰ）的含量， | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 剂盒（磁微粒 | | 20252400419 | 2030 | 年 | 03 | 月 16 | 日 | | | 产品名称 化学发光法）注 | 注册 分类 | 注册证编号 | | | 注册证有效期 | | | 适用范围 临床上主要用于生长紊乱 的辅助诊断。 | 证券代码：300832 证券简称：新产业 公告编号：2025-014 深圳市新产业生物医学工程股份有限公司 关于获得医疗器械注册证的公告 深圳市新产业生物医学工程股份有限公司 董事会 2025 年 3 月 19 ...

证券代码：300832 证券简称：新产业 公告编号：2025-013 二、 对公司的影响及风险提示 1 截至目前，公司已先后取得 191 项化学发光试剂《医疗器械注册证》（共 272 个注册证）。以上试剂新产品医疗器械注册证的取得，丰富了公司化学发光 检测产品中"肝纤维化"项目类别，将对公司发展具有正面影响，但对近期的 生产经营和业绩不会产生重大影响，敬请投资者给予关注并注意投资风险。 深圳市新产业生物医学工程股份有限公司 关于获得医疗器械注册证的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 近日，深圳市新产业生物医学工程股份有限公司（以下简称"公司"）收到 了广东省药品监督管理局颁发的 1 项《医疗器械注册证》。具体情况如下： | 产品名称 | | 注册 | 注册证编号 | | | 注册证有效期 | | | 适用范围 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 分类 | | | | | | | | | 高尔基体蛋白 | 73 | | 粤械注准 | 2025 ...